Successful gastrointestinal cancer drug development.

Abstract

A large number of new drugs have been approved over the past 10 years for the treatment of both common and rare gastrointestinal malignancies. Many other agents, however, have failed at a great cost of financial and patient resources. Drug development must identify potentially active compounds and reveal the most effective and least toxic manner and… (More)

Topics

  • Presentations referencing similar topics